Table: begin end state 1 16 non-cytoplasmic 17 38 transmembrane 39 59 cytoplasmic 60 87 transmembrane 88 91 non-cytoplasmic 92 113 transmembrane 114 141 cytoplasmic 142 162 transmembrane 163 179 non-cytoplasmic 180 199 transmembrane 200 209 cytoplasmic 210 230 transmembrane 231 236 non-cytoplasmic 237 263 transmembrane 264 303 cytoplasmic 304 327 transmembrane 328 360 non-cytoplasmic 361 381 transmembrane 382 387 cytoplasmic 388 411 transmembrane 412 423 non-cytoplasmic 424 444 transmembrane 445 461 cytoplasmic
Input: >WP_046009929.1 NCBI__GCF_000967895.1:WP_046009929.1 MVDIINTINGWAWGPPMLLLIAITGLFLTLGLKAYPILNIKKGFSLLWSGRKAKGEGDIS GFNALMTSLSATIGTGNIAGVATAIAMGGPGALFWMWMIALIGMATKYSEAVLAVHYREK DENGNFVGGPMYYIKNGLGVNWKWMATAFAFFGMIAGFGIGNGVQANSVADVMHSSFQVS ELTTGIIMAILAALVLLGGIKRIATVAGKLVPFMAITYIIGGLILLVIYFDRIPAAFSTI LTYAFTPASAAGGFAGASVWMAIRFGIARGVFSNEAGLGSAPIAHAAAQTNNPVQQGTIA MLGTFIDTLVICTITGLVIVASGAWQVIDPGTGKALSGANLTAAAFSQGFPSIGGFNFGE MIVTFGLIIFAFTTLLGWSFYGEKCAEYLFGVKSIIIFRIVWVLAIPIGATFELDLAWLV ADTLNALMALPNLVALLLLSPVVFKLTKAAQKKSALDKEAS
Or try the official Phobius web server, which has a different display
Reference: Advantages of combined transmembrane topology and signal peptide prediction - the Phobius web server